| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase I | 47 | 2025 | 48 | 6.810 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 45 | 2014 | 46 | 5.250 |
Why?
|
| Transcription, Genetic | 58 | 2021 | 399 | 4.130 |
Why?
|
| Transcription Factors | 43 | 2021 | 511 | 3.770 |
Why?
|
| DNA, Ribosomal | 43 | 2021 | 157 | 3.610 |
Why?
|
| RNA, Ribosomal | 30 | 2021 | 51 | 2.210 |
Why?
|
| DNA-Binding Proteins | 36 | 2014 | 482 | 2.060 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2021 | 172 | 1.520 |
Why?
|
| Protein Multimerization | 4 | 2021 | 53 | 1.500 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2021 | 110 | 1.190 |
Why?
|
| Animals | 107 | 2021 | 9932 | 1.190 |
Why?
|
| Rats | 73 | 2014 | 1539 | 1.140 |
Why?
|
| Ribosomes | 7 | 2021 | 31 | 0.980 |
Why?
|
| Nuclear Proteins | 7 | 2014 | 245 | 0.940 |
Why?
|
| Promoter Regions, Genetic | 17 | 2013 | 333 | 0.870 |
Why?
|
| Carrier Proteins | 5 | 2014 | 244 | 0.860 |
Why?
|
| Gene Expression Regulation | 13 | 2014 | 628 | 0.820 |
Why?
|
| DNA | 18 | 2013 | 364 | 0.800 |
Why?
|
| Transcription Factors, TFII | 1 | 2020 | 4 | 0.740 |
Why?
|
| Mammals | 1 | 2021 | 46 | 0.740 |
Why?
|
| Mitosis | 4 | 2019 | 109 | 0.730 |
Why?
|
| Cell Nucleolus | 15 | 2021 | 25 | 0.730 |
Why?
|
| Phosphoproteins | 10 | 2006 | 115 | 0.710 |
Why?
|
| Sodium-Calcium Exchanger | 13 | 2007 | 20 | 0.690 |
Why?
|
| Mice | 30 | 2019 | 4396 | 0.690 |
Why?
|
| Myocardium | 12 | 2007 | 171 | 0.650 |
Why?
|
| Protein Binding | 14 | 2020 | 631 | 0.640 |
Why?
|
| Myocytes, Cardiac | 10 | 2006 | 59 | 0.640 |
Why?
|
| Myocardial Contraction | 13 | 2006 | 60 | 0.630 |
Why?
|
| Cardiomegaly | 7 | 2003 | 18 | 0.630 |
Why?
|
| Transfection | 17 | 2006 | 312 | 0.600 |
Why?
|
| Retinoblastoma Protein | 5 | 2001 | 9 | 0.590 |
Why?
|
| Cell Line | 21 | 2013 | 672 | 0.570 |
Why?
|
| Amino Acid Sequence | 9 | 2019 | 673 | 0.560 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2016 | 13 | 0.560 |
Why?
|
| Base Sequence | 25 | 2016 | 573 | 0.530 |
Why?
|
| Molecular Sequence Data | 16 | 2014 | 1034 | 0.510 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 17 | 0.470 |
Why?
|
| Cell Nucleus | 14 | 2002 | 135 | 0.470 |
Why?
|
| Membrane Proteins | 10 | 2006 | 466 | 0.460 |
Why?
|
| Protein Domains | 2 | 2025 | 48 | 0.420 |
Why?
|
| Cells, Cultured | 22 | 2014 | 968 | 0.420 |
Why?
|
| Chromatin | 10 | 2020 | 73 | 0.420 |
Why?
|
| Calcium | 11 | 2007 | 231 | 0.400 |
Why?
|
| Peptides | 1 | 2014 | 279 | 0.400 |
Why?
|
| Humans | 38 | 2025 | 26777 | 0.380 |
Why?
|
| Protein Conformation | 4 | 2021 | 250 | 0.370 |
Why?
|
| Protein Subunits | 3 | 2020 | 40 | 0.370 |
Why?
|
| 3T3 Cells | 6 | 2002 | 44 | 0.360 |
Why?
|
| Dimerization | 2 | 2020 | 75 | 0.350 |
Why?
|
| HEK293 Cells | 3 | 2016 | 171 | 0.350 |
Why?
|
| NIH 3T3 Cells | 7 | 2016 | 44 | 0.340 |
Why?
|
| Phosphorylation | 13 | 2009 | 558 | 0.340 |
Why?
|
| Cloning, Molecular | 14 | 2006 | 204 | 0.320 |
Why?
|
| RNA, Messenger | 8 | 2003 | 645 | 0.320 |
Why?
|
| Genes, Reporter | 5 | 2002 | 88 | 0.320 |
Why?
|
| Liver Neoplasms, Experimental | 11 | 1998 | 27 | 0.310 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2005 | 542 | 0.310 |
Why?
|
| Macromolecular Substances | 2 | 2008 | 52 | 0.300 |
Why?
|
| Cricetinae | 9 | 2014 | 129 | 0.300 |
Why?
|
| CHO Cells | 8 | 2014 | 96 | 0.280 |
Why?
|
| Myocardial Infarction | 6 | 2005 | 342 | 0.270 |
Why?
|
| Recombinant Proteins | 12 | 2005 | 407 | 0.270 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2002 | 19 | 0.250 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2025 | 1 | 0.250 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 6 | 0.250 |
Why?
|
| Evolution, Molecular | 1 | 2025 | 80 | 0.240 |
Why?
|
| Blotting, Western | 11 | 2009 | 503 | 0.240 |
Why?
|
| Genetic Vectors | 4 | 2002 | 107 | 0.240 |
Why?
|
| Models, Molecular | 3 | 2025 | 441 | 0.230 |
Why?
|
| RNA, Ribosomal, 18S | 2 | 2020 | 4 | 0.220 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 9 | 0.210 |
Why?
|
| Fibroblasts | 4 | 2000 | 152 | 0.210 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2012 | 228 | 0.210 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2002 | 4 | 0.210 |
Why?
|
| Cyclins | 1 | 2002 | 8 | 0.210 |
Why?
|
| Gene Expression | 8 | 2004 | 406 | 0.200 |
Why?
|
| Cell Division | 7 | 2016 | 153 | 0.200 |
Why?
|
| Membrane Glycoproteins | 2 | 2007 | 142 | 0.200 |
Why?
|
| Proteins | 2 | 2002 | 244 | 0.200 |
Why?
|
| RNA | 2 | 2013 | 105 | 0.190 |
Why?
|
| Urinary Bladder | 1 | 2002 | 118 | 0.190 |
Why?
|
| Cycloheximide | 4 | 2008 | 10 | 0.190 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2020 | 1 | 0.190 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2020 | 6 | 0.190 |
Why?
|
| Chromatography, Affinity | 2 | 1998 | 32 | 0.180 |
Why?
|
| Contact Inhibition | 1 | 2000 | 1 | 0.180 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2008 | 13 | 0.180 |
Why?
|
| Cell Cycle | 3 | 2016 | 155 | 0.180 |
Why?
|
| Animals, Newborn | 5 | 2002 | 163 | 0.180 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 2009 | 164 | 0.180 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2019 | 1 | 0.170 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2019 | 3 | 0.170 |
Why?
|
| Indoleacetic Acids | 1 | 2019 | 7 | 0.170 |
Why?
|
| RNA, Guide | 1 | 2019 | 14 | 0.170 |
Why?
|
| Multienzyme Complexes | 1 | 1999 | 29 | 0.170 |
Why?
|
| Antigens, Nuclear | 1 | 1999 | 22 | 0.170 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 43 | 0.170 |
Why?
|
| DNA Replication | 1 | 1999 | 49 | 0.170 |
Why?
|
| DNA Repair | 1 | 1999 | 82 | 0.160 |
Why?
|
| DNA Helicases | 1 | 1999 | 51 | 0.160 |
Why?
|
| Templates, Genetic | 5 | 2008 | 9 | 0.160 |
Why?
|
| Insecta | 2 | 2013 | 24 | 0.160 |
Why?
|
| RNA Precursors | 3 | 2000 | 9 | 0.150 |
Why?
|
| Muscles | 3 | 2006 | 70 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1985 | 31 | 0.150 |
Why?
|
| Cricetulus | 2 | 2014 | 56 | 0.140 |
Why?
|
| Nucleolus Organizer Region | 4 | 2001 | 4 | 0.140 |
Why?
|
| Heart | 2 | 1995 | 219 | 0.140 |
Why?
|
| Mutagenesis | 4 | 2013 | 45 | 0.140 |
Why?
|
| Proteoglycans | 1 | 1997 | 37 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 4 | 2012 | 283 | 0.140 |
Why?
|
| Protein Kinases | 6 | 2009 | 143 | 0.140 |
Why?
|
| Endothelins | 1 | 1996 | 7 | 0.130 |
Why?
|
| Precipitin Tests | 4 | 2003 | 47 | 0.130 |
Why?
|
| Sequence Alignment | 2 | 2012 | 110 | 0.130 |
Why?
|
| Adrenergic Agents | 1 | 1995 | 3 | 0.130 |
Why?
|
| Norepinephrine | 1 | 1995 | 32 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 7 | 0.120 |
Why?
|
| Immunohistochemistry | 6 | 2005 | 453 | 0.120 |
Why?
|
| Spinal Cord | 1 | 1997 | 202 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2014 | 33 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2014 | 24 | 0.120 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 31 | 0.120 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 24 | 0.120 |
Why?
|
| Mutation | 8 | 2006 | 818 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 1995 | 394 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 8 | 2000 | 310 | 0.120 |
Why?
|
| DNA, Neoplasm | 4 | 2005 | 33 | 0.120 |
Why?
|
| Calcium-Transporting ATPases | 5 | 2005 | 9 | 0.120 |
Why?
|
| Brain | 2 | 1997 | 696 | 0.110 |
Why?
|
| Calcium Signaling | 2 | 2005 | 68 | 0.110 |
Why?
|
| High Mobility Group Proteins | 2 | 1996 | 4 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2013 | 130 | 0.110 |
Why?
|
| Deoxyribonuclease I | 2 | 1990 | 8 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2002 | 44 | 0.110 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2013 | 1 | 0.110 |
Why?
|
| Transcription Factor TFIID | 1 | 2013 | 2 | 0.110 |
Why?
|
| Phenotype | 2 | 2014 | 663 | 0.110 |
Why?
|
| Models, Genetic | 5 | 2008 | 122 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2012 | 20 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 34 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 115 | 0.100 |
Why?
|
| Genes | 5 | 1986 | 34 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 10 | 1989 | 73 | 0.100 |
Why?
|
| Molecular Weight | 8 | 1999 | 118 | 0.100 |
Why?
|
| Blood | 1 | 1992 | 33 | 0.100 |
Why?
|
| Time Factors | 4 | 2002 | 1564 | 0.100 |
Why?
|
| Histones | 3 | 2014 | 90 | 0.100 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 77 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 2001 | 7 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2014 | 762 | 0.090 |
Why?
|
| Calcium Channels | 2 | 2002 | 32 | 0.090 |
Why?
|
| DNA, Recombinant | 2 | 1993 | 9 | 0.090 |
Why?
|
| DNA Restriction Enzymes | 8 | 1986 | 11 | 0.090 |
Why?
|
| Apoptosis | 1 | 2014 | 738 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2001 | 113 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1258 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 7 | 2004 | 100 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 20 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2007 | 10 | 0.080 |
Why?
|
| Down-Regulation | 3 | 2004 | 197 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2007 | 60 | 0.080 |
Why?
|
| HeLa Cells | 5 | 2009 | 206 | 0.080 |
Why?
|
| Genes, rRNA | 1 | 2008 | 69 | 0.080 |
Why?
|
| Uridine Triphosphate | 3 | 2000 | 3 | 0.080 |
Why?
|
| Sodium | 2 | 2006 | 47 | 0.080 |
Why?
|
| Peptide Mapping | 2 | 2002 | 22 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2007 | 6 | 0.080 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2007 | 13 | 0.080 |
Why?
|
| Male | 17 | 2007 | 12842 | 0.080 |
Why?
|
| Luminescent Proteins | 6 | 2002 | 25 | 0.080 |
Why?
|
| Genetic Complementation Test | 2 | 2002 | 24 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2007 | 33 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 1998 | 76 | 0.070 |
Why?
|
| Heparin | 1 | 2008 | 110 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2007 | 59 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2007 | 43 | 0.070 |
Why?
|
| Binding Sites | 2 | 2014 | 338 | 0.070 |
Why?
|
| Calsequestrin | 5 | 2006 | 7 | 0.070 |
Why?
|
| Species Specificity | 4 | 1996 | 185 | 0.070 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1986 | 3 | 0.070 |
Why?
|
| DNA, Fungal | 1 | 2006 | 6 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2006 | 57 | 0.070 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1984 | 5 | 0.070 |
Why?
|
| Models, Biological | 3 | 2006 | 446 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2008 | 110 | 0.070 |
Why?
|
| Adenoviridae | 5 | 2004 | 65 | 0.070 |
Why?
|
| DNA Primers | 2 | 1996 | 143 | 0.070 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 2005 | 3 | 0.070 |
Why?
|
| Protein Biosynthesis | 5 | 2009 | 106 | 0.070 |
Why?
|
| Ion Channel Gating | 1 | 2005 | 18 | 0.060 |
Why?
|
| Chromosome Mapping | 3 | 1997 | 130 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2002 | 72 | 0.060 |
Why?
|
| Gene Amplification | 1 | 1985 | 22 | 0.060 |
Why?
|
| Fluorescent Dyes | 5 | 2005 | 87 | 0.060 |
Why?
|
| Escherichia coli | 2 | 2002 | 328 | 0.060 |
Why?
|
| CREB-Binding Protein | 2 | 2001 | 10 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 4 | 2006 | 30 | 0.060 |
Why?
|
| Acetylation | 2 | 2001 | 34 | 0.060 |
Why?
|
| Hypertrophy | 2 | 2002 | 37 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 2 | 2004 | 34 | 0.060 |
Why?
|
| RNA Polymerase III | 1 | 1984 | 5 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2005 | 111 | 0.060 |
Why?
|
| Running | 2 | 2004 | 39 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1995 | 77 | 0.060 |
Why?
|
| Nucleoproteins | 3 | 1979 | 7 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2003 | 2 | 0.060 |
Why?
|
| Physical Exertion | 1 | 2004 | 98 | 0.060 |
Why?
|
| Receptors, Erythropoietin | 2 | 2002 | 3 | 0.060 |
Why?
|
| Kidney | 4 | 2005 | 275 | 0.060 |
Why?
|
| Spodoptera | 1 | 2003 | 4 | 0.050 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 12 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2000 | 86 | 0.050 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2005 | 17 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 15 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2002 | 12 | 0.050 |
Why?
|
| Enzyme Activation | 4 | 2005 | 262 | 0.050 |
Why?
|
| Ion Channels | 1 | 2002 | 22 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 12 | 0.050 |
Why?
|
| Indicators and Reagents | 4 | 2002 | 26 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2014 | 28 | 0.050 |
Why?
|
| Kinetics | 3 | 2002 | 538 | 0.050 |
Why?
|
| Organ Size | 1 | 2002 | 83 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2006 | 31 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 48 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 22 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2001 | 77 | 0.050 |
Why?
|
| Artifacts | 1 | 2002 | 48 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 23 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2001 | 18 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2001 | 26 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2001 | 36 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 83 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2006 | 122 | 0.050 |
Why?
|
| RNA, Small Nuclear | 2 | 1994 | 4 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2000 | 1 | 0.050 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2000 | 1 | 0.050 |
Why?
|
| Genes, Retinoblastoma | 1 | 2000 | 1 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2000 | 22 | 0.050 |
Why?
|
| Nucleotide Mapping | 2 | 1990 | 2 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 247 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2000 | 10 | 0.040 |
Why?
|
| Exercise | 1 | 2004 | 442 | 0.040 |
Why?
|
| Cell Extracts | 2 | 1992 | 14 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1998 | 8 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 98 | 0.040 |
Why?
|
| Holoenzymes | 1 | 1999 | 2 | 0.040 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 1999 | 7 | 0.040 |
Why?
|
| Ku Autoantigen | 1 | 1999 | 12 | 0.040 |
Why?
|
| Action Potentials | 3 | 2006 | 193 | 0.040 |
Why?
|
| Serine | 3 | 2006 | 48 | 0.040 |
Why?
|
| Caffeine | 3 | 2003 | 38 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 1990 | 14 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 159 | 0.040 |
Why?
|
| Fura-2 | 3 | 2002 | 10 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 2005 | 94 | 0.040 |
Why?
|
| Xenopus | 3 | 1999 | 28 | 0.040 |
Why?
|
| Syndecan-3 | 1 | 1997 | 1 | 0.040 |
Why?
|
| Genomic Library | 1 | 1997 | 10 | 0.040 |
Why?
|
| Exons | 1 | 1997 | 41 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 1996 | 9 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 1997 | 17 | 0.040 |
Why?
|
| Ribosomal Proteins | 2 | 2012 | 20 | 0.040 |
Why?
|
| Introns | 1 | 1997 | 41 | 0.040 |
Why?
|
| DNA Damage | 2 | 2014 | 149 | 0.040 |
Why?
|
| Neoplasm Proteins | 4 | 1979 | 122 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1996 | 13 | 0.030 |
Why?
|
| Prostate | 1 | 1996 | 51 | 0.030 |
Why?
|
| Insulin | 1 | 1998 | 310 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 2000 | 47 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 3 | 1987 | 90 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2009 | 68 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1996 | 3 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1996 | 24 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1996 | 72 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1996 | 26 | 0.030 |
Why?
|
| Homeostasis | 2 | 2007 | 114 | 0.030 |
Why?
|
| Angiotensin II | 1 | 1995 | 54 | 0.030 |
Why?
|
| Plasmids | 2 | 1988 | 121 | 0.030 |
Why?
|
| Membrane Potentials | 2 | 2005 | 61 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1995 | 3 | 0.030 |
Why?
|
| Cisplatin | 1 | 1996 | 172 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1995 | 19 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 33 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 9 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 42 | 0.030 |
Why?
|
| Muscle Cells | 2 | 2006 | 15 | 0.030 |
Why?
|
| Multigene Family | 1 | 2014 | 50 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 131 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 106 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 1993 | 262 | 0.030 |
Why?
|
| Oligonucleotides | 2 | 2002 | 27 | 0.030 |
Why?
|
| Computer Simulation | 3 | 2002 | 221 | 0.030 |
Why?
|
| Myogenin | 1 | 1993 | 4 | 0.030 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1993 | 6 | 0.030 |
Why?
|
| Cell Size | 2 | 2004 | 22 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 270 | 0.030 |
Why?
|
| Computational Biology | 1 | 2014 | 150 | 0.030 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 12 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1993 | 50 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2006 | 780 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1993 | 86 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1993 | 52 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 115 | 0.030 |
Why?
|
| Transcription Factors, TFIII | 1 | 2012 | 1 | 0.030 |
Why?
|
| Aorta | 1 | 1993 | 123 | 0.030 |
Why?
|
| Casein Kinases | 1 | 1992 | 1 | 0.030 |
Why?
|
| Glutaral | 1 | 1992 | 7 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 1995 | 841 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1992 | 90 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 2005 | 24 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 31 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 1991 | 12 | 0.020 |
Why?
|
| Female | 4 | 2007 | 14421 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 26 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1993 | 47 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 18 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 652 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2009 | 1337 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 20 | 0.020 |
Why?
|
| Age Factors | 2 | 2002 | 714 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 1471 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2009 | 29 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 47 | 0.020 |
Why?
|
| HMG-Box Domains | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2008 | 17 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 63 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2008 | 117 | 0.020 |
Why?
|
| Neoplasms | 1 | 1977 | 748 | 0.020 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Amino Acids | 1 | 1988 | 80 | 0.020 |
Why?
|
| Peptide Elongation Factors | 2 | 1978 | 5 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 2003 | 127 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1987 | 11 | 0.020 |
Why?
|
| Acute Disease | 1 | 2007 | 156 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2008 | 149 | 0.020 |
Why?
|
| Biopsy | 1 | 2007 | 199 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1987 | 13 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 67 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1987 | 200 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1986 | 1 | 0.020 |
Why?
|
| Endopeptidase K | 1 | 1986 | 4 | 0.020 |
Why?
|
| Sequence Deletion | 2 | 1999 | 65 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2006 | 7 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 30 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1986 | 20 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2006 | 3 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 36 | 0.020 |
Why?
|
| Colforsin | 1 | 2006 | 12 | 0.020 |
Why?
|
| Ions | 1 | 2006 | 18 | 0.020 |
Why?
|
| Alanine | 1 | 2006 | 40 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2005 | 5 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 9 | 0.020 |
Why?
|
| Vault Ribonucleoprotein Particles | 1 | 2005 | 2 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 17 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 50 | 0.020 |
Why?
|
| Autoradiography | 1 | 1985 | 28 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2006 | 47 | 0.020 |
Why?
|
| Exoribonucleases | 1 | 1985 | 20 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 115 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2005 | 5 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1986 | 229 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 102 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 129 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 239 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 161 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2005 | 282 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1984 | 48 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 93 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1984 | 11 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 2003 | 1 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 504 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 158 | 0.010 |
Why?
|
| Cell-Free System | 3 | 1978 | 21 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 6 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 235 | 0.010 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 37 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2004 | 77 | 0.010 |
Why?
|
| Sirolimus | 1 | 2003 | 68 | 0.010 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2002 | 4 | 0.010 |
Why?
|
| Haplorhini | 1 | 2002 | 15 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2002 | 16 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 316 | 0.010 |
Why?
|
| Fluorescence | 1 | 2002 | 47 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 587 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 75 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 25 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 77 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 2002 | 9 | 0.010 |
Why?
|
| TRPM Cation Channels | 1 | 2002 | 6 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2002 | 41 | 0.010 |
Why?
|
| Microscopy | 1 | 2002 | 38 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 240 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 23 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2001 | 18 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1984 | 284 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2002 | 146 | 0.010 |
Why?
|
| Vasodilation | 1 | 2002 | 114 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 323 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 130 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2001 | 253 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2000 | 5 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 62 | 0.010 |
Why?
|
| Base Composition | 1 | 1981 | 107 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 149 | 0.010 |
Why?
|
| Microinjections | 1 | 2000 | 14 | 0.010 |
Why?
|
| Silver | 1 | 1979 | 21 | 0.010 |
Why?
|
| Ion Transport | 1 | 1999 | 11 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1979 | 67 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1977 | 130 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1999 | 3 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 90 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 2000 | 150 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1977 | 164 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1998 | 11 | 0.010 |
Why?
|
| Chromosomes | 1 | 1998 | 59 | 0.010 |
Why?
|
| Crystallography | 1 | 1998 | 6 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1998 | 73 | 0.010 |
Why?
|
| Enzyme Repression | 1 | 1977 | 1 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1977 | 57 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1977 | 7 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1996 | 12 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1977 | 50 | 0.010 |
Why?
|
| DNA Adducts | 1 | 1996 | 6 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 51 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 6796 | 0.010 |
Why?
|
| Testosterone | 1 | 1996 | 70 | 0.010 |
Why?
|
| Crystallization | 1 | 1996 | 47 | 0.010 |
Why?
|
| Casein Kinase II | 1 | 1995 | 17 | 0.010 |
Why?
|
| Adult | 1 | 2007 | 7359 | 0.010 |
Why?
|
| Ribonuclease T1 | 2 | 1986 | 2 | 0.010 |
Why?
|
| Lipids | 1 | 1996 | 195 | 0.010 |
Why?
|
| Interphase | 1 | 1994 | 6 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 245 | 0.010 |
Why?
|
| Mifepristone | 1 | 1993 | 4 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 441 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 26 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 24 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1993 | 31 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1993 | 18 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1993 | 54 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1993 | 81 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1993 | 56 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 340 | 0.010 |
Why?
|
| Liver | 2 | 1986 | 415 | 0.010 |
Why?
|
| Uridine Monophosphate | 1 | 1989 | 2 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1989 | 10 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1989 | 25 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1989 | 45 | 0.010 |
Why?
|
| Uridine | 1 | 1989 | 6 | 0.010 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1983 | 5 | 0.000 |
Why?
|
| Endoribonucleases | 1 | 1983 | 9 | 0.000 |
Why?
|
| Silver Nitrate | 1 | 1979 | 2 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1979 | 65 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1978 | 19 | 0.000 |
Why?
|
| RNA, Transfer | 1 | 1978 | 16 | 0.000 |
Why?
|
| Poly A | 1 | 1977 | 5 | 0.000 |
Why?
|
| Liver Regeneration | 1 | 1977 | 6 | 0.000 |
Why?
|
| Triticum | 1 | 1977 | 17 | 0.000 |
Why?
|